Trial intelligence / Profile preview

DA-020 for Chemotherapy Induced Alopecia

NCT07397325Phase 2Recruiting

Start
May 2026
Primary completion
Feb 2027
Modality
Small Molecules
Countries
2
01

Overview

A Phase 2 trial of Mucinex Full Force Nasal Spray in Chemotherapy-induced alopecia (CIA). Started May 2026; status: recruiting.

02

Drugs

Mucinex Full Force Nasal Spray
03

Conditions

Chemotherapy-induced alopecia (CIA)

Beyond the preview

Go deeper on NCT07397325.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07397325.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call